Integral Diagnostics Ltd
ASX:IDX
If you don’t study any companies, you have the same success buying stocks as you do in a poker game if you bet without looking at your cards.
Utilize notes to systematically review your investment decisions. By reflecting on past outcomes, you can discern effective strategies and identify those that underperformed. This continuous feedback loop enables you to adapt and refine your approach, optimizing for future success.
Each note serves as a learning point, offering insights into your decision-making processes. Over time, you'll accumulate a personalized database of knowledge, enhancing your ability to make informed decisions quickly and effectively.
With a comprehensive record of your investment history at your fingertips, you can compare current opportunities against past experiences. This not only bolsters your confidence but also ensures that each decision is grounded in a well-documented rationale.
Do you really want to delete this note?
This action cannot be undone.
| 52 Week Range |
1.66
3.17
|
| Price Target |
|
We'll email you a reminder when the closing price reaches AUD.
Choose the stock you wish to monitor with a price alert.
This alert will be permanently deleted.
Integral Diagnostics Ltd
Integral Diagnostics Ltd
Cost of Revenue
Integral Diagnostics Ltd
Cost of Revenue Peer Comparison
Competitors Analysis
Latest Figures & CAGR of Competitors
| Company | Cost of Revenue | CAGR 3Y | CAGR 5Y | CAGR 10Y | ||
|---|---|---|---|---|---|---|
|
|
Integral Diagnostics Ltd
ASX:IDX
|
Cost of Revenue
-AU$22.9m
|
CAGR 3-Years
-10%
|
CAGR 5-Years
-17%
|
CAGR 10-Years
N/A
|
|
|
Healthia Ltd
ASX:HLA
|
Cost of Revenue
-AU$20.6m
|
CAGR 3-Years
-44%
|
CAGR 5-Years
-31%
|
CAGR 10-Years
N/A
|
|
|
Sonic Healthcare Ltd
ASX:SHL
|
Cost of Revenue
-AU$1.5B
|
CAGR 3-Years
4%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
-9%
|
|
|
Capitol Health Ltd
ASX:CAJ
|
Cost of Revenue
-AU$16m
|
CAGR 3-Years
-7%
|
CAGR 5-Years
-6%
|
CAGR 10-Years
-16%
|
|
|
Australian Clinical Labs Ltd
ASX:ACL
|
Cost of Revenue
-AU$119.3m
|
CAGR 3-Years
0%
|
CAGR 5-Years
-8%
|
CAGR 10-Years
N/A
|
|
|
H
|
Healius Ltd
ASX:HLS
|
Cost of Revenue
-AU$224.3m
|
CAGR 3-Years
6%
|
CAGR 5-Years
-3%
|
CAGR 10-Years
-4%
|
|
Integral Diagnostics Ltd
Glance View
Integral Diagnostics Ltd. engages in the provision of diagnostic imaging services to general practitioners, medical specialists, and allied professionals. The company is headquartered in Melbourne, Victoria. The company went IPO on 2015-10-21. The firm is principally engaged in providing medical imaging services to patients and their referrers across Australia and New Zealand. The firm offers its services through its three brands in Australian states, which include Lake Imaging in Victoria, South Coast Radiology and Imaging Queensland in Queensland and Apex Radiology in Western Australia. IDX also operates in New Zealand through the Ascot Radiology, SRG Radiology and Trinity MRI brands. The firm has approximately 72 radiology clinics, including 26 comprehensive sites. IDX offers its services through its subsidiaries.
See Also
What is Integral Diagnostics Ltd's Cost of Revenue?
Cost of Revenue
-22.9m
AUD
Based on the financial report for Jun 30, 2024, Integral Diagnostics Ltd's Cost of Revenue amounts to -22.9m AUD.
What is Integral Diagnostics Ltd's Cost of Revenue growth rate?
Cost of Revenue CAGR 5Y
-17%
Over the last year, the Cost of Revenue growth was -9%. The average annual Cost of Revenue growth rates for Integral Diagnostics Ltd have been -10% over the past three years , -17% over the past five years .
You don't have any saved screeners yet
